2022
DOI: 10.1177/2050313x221093452
|View full text |Cite
|
Sign up to set email alerts
|

Trichodysplasia spinulosa in a bone marrow transplant recipient: A case report

Abstract: Trichodysplasia spinulosa is a rare skin condition seen in immunocompromised patients, especially in solid organ recipients. A recent review of the literature mentioned that there are 60 reported cases. We report a case in a patient with an allogenic bone marrow transplant. The patient developed white spiky protrusions on different areas of the face which improved after decreasing immunosuppression.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Trichodysplasia spinulosa is a rare disease primarily described in immunocompromised patients, commonly following solid organ transplant, but also in patients with immunosuppression due to medications, human immunodeficiency virus, bone marrow transplant, and cancer. 1,2 TS is caused by TS-associated polyomavirus (TSPyV), a deoxyribonucleic acid (DNA) virus which was discovered in the keratotic spines of a patient with TS. 3 Like BK and John Cunningham (JC) polyomaviruses, TSPyV becomes pathogenic in a small percentage of immunosuppressed patients.…”
Section: Discussionmentioning
confidence: 99%
“…Trichodysplasia spinulosa is a rare disease primarily described in immunocompromised patients, commonly following solid organ transplant, but also in patients with immunosuppression due to medications, human immunodeficiency virus, bone marrow transplant, and cancer. 1,2 TS is caused by TS-associated polyomavirus (TSPyV), a deoxyribonucleic acid (DNA) virus which was discovered in the keratotic spines of a patient with TS. 3 Like BK and John Cunningham (JC) polyomaviruses, TSPyV becomes pathogenic in a small percentage of immunosuppressed patients.…”
Section: Discussionmentioning
confidence: 99%